Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Dana Hurley"'
Autor:
Sudha Xirasagar, Meng-han Tsai, Khosrow Heidari, James W. Hardin, Yuqi Wu, Robert Wronski, Dana Hurley, Edward C. Jauch, Souvik Sen
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Patients with acute ischemic stroke (AIS) who use emergency medical services (EMS) receive quicker reperfusion treatment which, in turn, mitigates post-stroke disability. However, nationally only 59% use EMS. We examined why AIS p
Externí odkaz:
https://doaj.org/article/1e7989dd87e146b686398ce52942f40c
Publikováno v:
ASCEND 2022.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::650bdedb064252580a4ba1b86637b278
https://doi.org/10.2514/6.2022-4349
https://doi.org/10.2514/6.2022-4349
Autor:
Edward C. Jauch, Souvik Sen, Sudha Xirasagar, Dana Hurley, Jiera Zhou, Yuqi Wu, Robert Wronski, Meng-Han Tsai, Khosrow Heidari, James W. Hardin
Publikováno v:
J Gen Intern Med
BACKGROUND: Whether emergency medical services (EMS) transport improves disability outcomes compared with other transport among acute ischemic stroke (AIS) patients is unknown. OBJECTIVE: To study severity-adjusted associations of hospital arrival mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9251a2db3b771845a7d8c75209b585e8
https://doi.org/10.1007/s11606-020-06114-4
https://doi.org/10.1007/s11606-020-06114-4
Autor:
Yuqi Wu, Meng-Han Tsai, Sudha Xirasagar, Khosrow Heidari, James W. Hardin, Dana Hurley, Edward C. Jauch, Souvik Sen, Robert Wronski
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-11 (2019)
BMC Health Services Research
BMC Health Services Research
Background Patients with acute ischemic stroke (AIS) who use emergency medical services (EMS) receive quicker reperfusion treatment which, in turn, mitigates post-stroke disability. However, nationally only 59% use EMS. We examined why AIS patients u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52a027b7a49595ecf03c5b2f8c30b643
https://doi.org/10.1186/s12913-019-4741-6
https://doi.org/10.1186/s12913-019-4741-6
Autor:
Edward Feldmann, James C. Grotta, Patricia P. Katz, Pooja Khatri, Jose G. Romano, Scott E. Kasner, Riccardo Bianchi, Dana Hurley, Peter D. Panagos, Steven R. Levine, Joseph P. Broderick, Brett C. Meyer, Dimitre G. Stefanov, Clotilde Balucani, Doojin Kim, Sarah Weingast, Phillip A. Scott, Jeremy Weedon
Publikováno v:
Stroke. 49:1933-1938
Background and Purpose— The 2015 updated US Food and Drug Administration alteplase package insert altered several contraindications. We thus explored clinical factors influencing alteplase treatment decisions for patients with minor stroke. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54a75599207d7cc6fdc8747d3715d52c
https://doi.org/10.1161/strokeaha.118.020971
https://doi.org/10.1161/strokeaha.118.020971
Autor:
Brian G. Barnett, Dana Hurley, James A. Kaye, Isobel Pearson, Catherine Copley-Merriman, Beverly Moy, Tina Krieger, Catherine Masaquel
Publikováno v:
Cancer Research. 78:P3-10
Background: Despite available treatment for early-stage breast cancer (BC), 15%-25% of patients with early-stage human epidermal growth factor receptor 2–positive (HER2+) BC eventually experience recurrence after initial treatment. The prognosis fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa49a8cf1d3b2106b8b188287370bcf6
https://doi.org/10.1158/1538-7445.sabcs17-p3-10-14
https://doi.org/10.1158/1538-7445.sabcs17-p3-10-14
Autor:
Eric Q. Wu, Marco Paschoalin, Ella X Du, Keith A. Betts, Jinlin Song, Dana Hurley, Gautam Sajeev, Jenny Guo
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 26:1996-2003
In clinical trials, intravenous (IV) recombinant tissue-type plasminogen activator (rt-PA) reduces the likelihood of disability if given within 3 hours of acute ischemic stroke. This study compared real-world outcomes between patients treated and pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::470206e043ef6ded2b6f1821314115f4
https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.06.010
https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.06.010
Autor:
Amanda M. Kong, Dana Hurley, Kristin A Evans, Csilla Csoboth, Jeannie Visootsak, Diana I. Brixner
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 23:761-770
Individuals with Down syndrome (DS) experience various comorbidities in excess of the prevalence seen among the non-DS population. However, the extent of the excess burden of comorbidities specifically within commercially and publicly insured DS popu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1c3e5469dba9c3ac8c2cf824d8a68a9
https://doi.org/10.18553/jmcp.2017.23.7.761
https://doi.org/10.18553/jmcp.2017.23.7.761
Autor:
Steven R, Levine, Sarah Z, Weingast, Jeremy, Weedon, Dimitre G, Stefanov, Patricia, Katz, Dana, Hurley, Scott E, Kasner, Pooja, Khatri, Joseph P, Broderick, James C, Grotta, Edward, Feldmann, Peter D, Panagos, Jose G, Romano, Riccardo, Bianchi, Brett C, Meyer, Phillip A, Scott, Doojin, Kim, Clotilde, Balucani
Publikováno v:
Stroke. 49(8)
Background and Purpose- The 2015 updated US Food and Drug Administration alteplase package insert altered several contraindications. We thus explored clinical factors influencing alteplase treatment decisions for patients with minor stroke. Methods-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::83f87502ad5d0089d2db22ef1d42641c
https://pubmed.ncbi.nlm.nih.gov/29976582
https://pubmed.ncbi.nlm.nih.gov/29976582
Autor:
Joseph P. Broderick, Dana Hurley, Phillip A. Scott, Steven R. Levine, Doojin Kim, Riccardo Bianchi, Dimitre G. Stefanov, Sarah Weingast, Jose G. Romano, Peter D. Panagos, Pooja Khatri, Scott E. Kasner, Clotilde Balucani, Jeremy Weedon, Brett C. Meyer, Edward Feldmann, James C. Grotta, Patricia P. Katz
Publikováno v:
Stroke. 49
Introduction: The 2015 updated US FDA package insert for rt-PA allows for a greater degree of clinical judgment regarding contraindications; thus there is flexibility in the decision to treat or not to treat. Hypothesis: Identifiable clinical factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb1b50eae5b2ded3f4933ad7066905fb
https://doi.org/10.1161/str.49.suppl_1.tmp77
https://doi.org/10.1161/str.49.suppl_1.tmp77